Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.
Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice.
复制标题
DOI:
10.1126/scitranslmed.aaa7619
复制
发表时间:
2015-07-29
影响因子:
17.1
通讯作者:
Brown K
中科院分区:
文献类型:
--
作者:
Cai H;Scott E;Kholghi A;Andreadi C;Rufini A;Karmokar A;Britton RG;Horner-Glister E;Greaves P;Jawad D;James M;Howells L;Ognibene T;Malfatti M;Goldring C;Kitteringham N;Walsh J;Viskaduraki M;West K;Miller A;Hemingway D;Steward WP;Gescher AJ;Brown K
Resveratrol is widely promoted as a potential cancer chemopreventive agent, but a lack of information on the optimal dose prohibits rationally designed trials assessing efficacy. To challenge the assumption that ‘more is better’ we compared the pharmacokinetics and activity of a dietary dose with an intake 200-times higher. The dose response relationship and metabolite profile of [14C]-resveratrol in colorectal tissue of patients helped define clinically achievable concentrations. In ApcMin mice receiving a high-fat diet the low dose supressed intestinal adenoma development more potently than the higher dose. Efficacy correlated with increased AMP-activated protein kinase (AMPK) activation and the senescence marker p21. Non-linear dose responses were observed for AMPK and mTOR signalling in adenoma cells, culminating in autophagy and senescence. In human tissues low dietary exposures caused enhanced AMPK phosphorylation, autophagy and expression of the cytoprotective enzyme NQO1. These findings warrant revision of developmental strategies for diet-derived agents for cancer chemoprevention.